嘉实医药健康100ETF联接C(008155)申购赎回 |
|
报告期 |
期初总份额(份) |
期末总份额(份) |
期间总申购份额(份) |
期间总赎回份额(份) |
期间净申赎份额(份) |
净申赎比例 |
2024/3/31 |
251,801,000 |
244,454,000 |
65,578,300 |
72,925,900 |
-7,347,600 |
-2.92% |
2023/12/31 |
274,607,000 |
251,801,000 |
315,338,000 |
338,144,000 |
-22,806,000 |
-8.3% |
2023/12/31 |
263,805,000 |
251,801,000 |
63,164,000 |
75,167,600 |
-12,003,600 |
-4.55% |
2023/9/30 |
263,431,000 |
263,805,000 |
112,040,000 |
111,666,000 |
374,000 |
0.14% |
2023/6/30 |
274,607,000 |
263,431,000 |
140,133,000 |
151,310,000 |
-11,177,000 |
-4.07% |
2023/6/30 |
256,345,000 |
263,431,000 |
84,318,100 |
77,232,500 |
7,085,600 |
2.76% |
2023/3/31 |
274,607,000 |
256,345,000 |
55,815,200 |
74,077,200 |
-18,262,000 |
-6.65% |
2022/12/31 |
304,313,000 |
274,607,000 |
590,281,000 |
619,986,000 |
-29,705,000 |
-9.76% |
2022/12/31 |
310,539,000 |
274,607,000 |
94,464,000 |
130,396,000 |
-35,932,000 |
-11.57% |
2022/9/30 |
283,451,000 |
310,539,000 |
168,275,000 |
141,187,000 |
27,088,000 |
9.56% |
2022/6/30 |
304,313,000 |
283,451,000 |
327,541,000 |
348,403,000 |
-20,862,000 |
-6.86% |
2022/6/30 |
278,603,000 |
283,451,000 |
138,636,000 |
133,788,000 |
4,848,000 |
1.74% |
2022/3/31 |
304,313,000 |
278,603,000 |
188,905,000 |
214,615,000 |
-25,710,000 |
-8.45% |
2021/12/31 |
428,065,000 |
304,313,000 |
678,675,000 |
802,426,000 |
-123,751,000 |
-28.91% |
2021/12/31 |
226,238,000 |
304,313,000 |
246,903,000 |
168,828,000 |
78,075,000 |
34.51% |
2021/9/30 |
130,000,000 |
226,238,000 |
246,198,000 |
149,960,000 |
96,238,000 |
74.03% |
2021/6/30 |
428,065,000 |
130,000,000 |
185,573,000 |
483,638,000 |
-298,065,000 |
-69.63% |
2021/6/30 |
428,065,000 |
130,000,000 |
185,573,000 |
483,638,000 |
-298,065,000 |
-69.63% |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。